Skip to main content
. 2020 Oct 9;59(50):22494–22499. doi: 10.1002/anie.202006725

Figure 1.

Figure 1

left: Selected HDAC inhibitors and their typical design; right: intended targets of this work and of the hybrid compound tinostamustine.